Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein
Authors
Keywords
-
Journal
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-13
DOI
10.1007/s00253-022-12218-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanozyme-Based Enhanced Cancer Immunotherapy
- (2022) Ngoc Man Phan et al. Tissue Engineering and Regenerative Medicine
- Argininosuccinate synthase 1, arginine deprivation therapy and cancer management
- (2022) Naihui Sun et al. Frontiers in Pharmacology
- Enhanced efficiency of generating human-induced pluripotent stem cells using Lin28-30Kc19 fusion protein
- (2022) Boram Son et al. Frontiers in Bioengineering and Biotechnology
- Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences
- (2021) Anubhuti Kawatra et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Microbial enzymes for deprivation of amino acid metabolism in malignant cells: biological strategy for cancer treatment
- (2020) Rakhi Dhankhar et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Current technologies to endotoxin detection and removal for biopharmaceutical purification
- (2020) Mason Schneier et al. BIOTECHNOLOGY AND BIOENGINEERING
- Arginine depletion therapy with ADI-PEG20 limits tumor growth in argininosuccinate synthase deficient ovarian cancer, including small cell carcinoma of the ovary, hypercalcemic type
- (2020) Jennifer X Ji et al. CLINICAL CANCER RESEARCH
- Protein-based direct reprogramming of fibroblasts to neuronal cells using 30Kc19 protein and transcription factor Ascl1
- (2020) Jina Ryu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Intracellular Delivery of Recombinant RUNX2 Facilitated by Cell-Penetrating Protein for the Osteogenic Differentiation of hMSCs
- (2020) Haein Lee et al. ACS Biomaterials-Science & Engineering
- PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution
- (2019) Zahid Hussain et al. Drug Delivery and Translational Research
- A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma
- (2019) Peter E. Hall et al. CLINICAL CANCER RESEARCH
- Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity
- (2019) Ashraf S.A. El-Sayed et al. ENZYME AND MICROBIAL TECHNOLOGY
- MMP-Responsive ‘Smart’ Drug Delivery and Tumor Targeting
- (2018) Qing Yao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Enzyme delivery using protein-stabilizing and cell-penetrating 30Kc19α protein nanoparticles
- (2017) Hee Ho Park et al. PROCESS BIOCHEMISTRY
- Protein-stabilizing and cell-penetrating properties of α-helix domain of 30Kc19 protein
- (2016) Jina Ryu et al. Biotechnology Journal
- Arginine dependence of tumor cells: targeting a chink in cancer’s armor
- (2016) M D Patil et al. ONCOGENE
- Protein-stabilizing and cell-penetrating properties of α-helix domain of 30Kc19 protein
- (2016) Jina Ryu et al. Biotechnology Journal
- PEGylation in anti-cancer therapy: An overview
- (2016) Prajna Mishra et al. Asian Journal of Pharmaceutical Sciences
- Soluble expression and stability enhancement of transcription factors using 30Kc19 cell-penetrating protein
- (2015) Jina Ryu et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Synthetic fusion protein design and applications
- (2015) Kai Yu et al. BIOTECHNOLOGY ADVANCES
- Escherichia coli EDA is a novel fusion expression partner to improve solubility of aggregation-prone heterologous proteins
- (2015) Yoon-Sik Kang et al. JOURNAL OF BIOTECHNOLOGY
- Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells
- (2015) Tzyy-Harn Yeh et al. MOLECULAR PHARMACEUTICS
- Dimerization of 30Kc19 protein in the presence of amphiphilic moiety and importance of Cys-57 during cell penetration
- (2014) Hee Ho Park et al. Biotechnology Journal
- Synthesis of Mycoplasma arginine deiminase in E. coli using stress-responsive proteins
- (2014) Keum-Young Ahn et al. ENZYME AND MICROBIAL TECHNOLOGY
- Intracellular Delivery of Recombinant Arginine Deiminase (rADI) by Heparin-Binding Hemagglutinin Adhesion Peptide Restores Sensitivity in rADI-Resistant Cancer Cells
- (2014) Fe-Lin Lin Wu et al. MOLECULAR PHARMACEUTICS
- Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy
- (2014) Chun A. Changou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification and characterization of a novel cell-penetrating peptide of 30Kc19 protein derived from Bombyx mori
- (2014) Hee Ho Park et al. PROCESS BIOCHEMISTRY
- Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
- (2014) Melissa M. Phillips et al. Cancer Research and Treatment
- Discussion about Several Potential Drawbacks of PEGylated Therapeutic Proteins
- (2013) Fan Zhang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles
- (2013) Hong Jai Lee et al. BIOMATERIALS
- Improved method for expression and isolation of the Mycoplasma hominis arginine deiminase from the recombinant strain of Escherichia coli
- (2013) Lyubov R. Fayura et al. JOURNAL OF BIOTECHNOLOGY
- Tissue- and Cell-Specific Co-localization of Intracellular Gelatinolytic Activity and Matrix Metalloproteinase 2
- (2013) Ann Iren Solli et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction
- (2013) Yan Long et al. MOLECULAR CANCER THERAPEUTICS
- A protein delivery system using 30Kc19 cell-penetrating protein originating from silkworm
- (2012) Ju Hyun Park et al. BIOMATERIALS
- A novel Escherichia coli solubility enhancer protein for fusion expression of aggregation-prone heterologous proteins
- (2011) Jong-Am Song et al. ENZYME AND MICROBIAL TECHNOLOGY
- Crystal structure of the 30K protein from the silkworm Bombyx mori reveals a new member of the β-trefoil superfamily
- (2011) Jie-Pin Yang et al. JOURNAL OF STRUCTURAL BIOLOGY
- Stabilization of enzymes by the recombinant 30Kc19 protein
- (2011) Ju Hyun Park et al. PROCESS BIOCHEMISTRY
- Expression of Bombyx mori 30Kc19 protein in Escherichia coli and its anti-apoptotic effect in Sf9 cell
- (2009) Won Jong Rhee et al. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
- Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis
- (2009) R. H. Kim et al. CANCER RESEARCH
- Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1 /Sp4
- (2009) W.-B. Tsai et al. MOLECULAR CANCER THERAPEUTICS
- Arginine deiminase, a potential anti-tumor drug
- (2008) Ye Ni et al. CANCER LETTERS
- Inhibition of Apoptosis by a Bombyx mori Gene
- (2004) Eun Jeong Kim et al. BIOTECHNOLOGY PROGRESS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started